NDAORALCAPSULEPriority Review
Approved
Nov 1957
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Priority Review
Drug data last refreshed 24m ago · AI intelligence enriched 6d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Darvon Compound is a fixed-dose combination oral capsule containing propoxyphene hydrochloride (an opioid analgesic), aspirin (an NSAID), and caffeine for pain relief. It was approved in 1957 as a combination analgesic for moderate pain management. The product combines opioid, anti-inflammatory, and stimulant mechanisms to enhance pain relief.
LOE Approaching
This product is approaching loss of exclusivity with modest competitive pressure (30%), indicating a shrinking team and focus on transition planning rather than growth initiatives.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on Darvon Compound offers limited career growth due to the product's LOE-approaching status and minimal linked job openings (0 identified). This role is best suited for professionals seeking stable, legacy product management experience or transition planning expertise rather than launch-phase or growth-driven advancement.
Brand ManagerSenior Brand Manager
Worked on DARVON COMPOUND at Teva? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.